Clinical Study
HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients
Table 3
HOMA-IR according to viral characteristics of patients with chronic hepatitis C.
| Variables | | HOMA-IR | |
| Genotype | 92 | | | Non-3 | 74 (80.4%) | 1.94 (1.51–3.61) | 0.890 | 3 | 18 (19.6%) | 1.93 (1.46–3.56) | Fibrosis stage* | 89 | | | F0/F1 | 63 (70.8%) | 1.93 (1.51–2.93) | 0.207 | F2/F3 | 26 (29.2%) | 2.75 (1.55–3.95) | Viral load | 73 | | | >400.000 UI/mL | 55 (75.3%) | 1.53 (1.17–2.35) | 0.027 | <400.000 UI/mL | 18 (24.7%) | 2.21 (1.29–3.76) |
|
|
*METAVIR.
|